He developed spontaneous puberty (13 years of age) and he showed normal pubertal progression. However, from the age of 15 years, he had low normal testosterone, raised FSH and reduction of Anti-mullerian hormone and Inhibin B, possibly suggestive of declining testicular function. His final height was -2.24 SDS (-2.4 SDS at GH start; MPH -1.6 SDS). 
45,X/46,XY. The child grew along the 2 nd centile, within the mid parental height (MPH) range, until the time of puberty, when linear growth worsened due to a lack of a pubertal growth spurt and growth hormone (GH) therapy was initiated.
He developed spontaneous puberty (13 years of age) and he showed normal pubertal progression. However, from the age of 15 years, he had low normal testosterone, raised FSH and reduction of Anti-mullerian hormone and Inhibin B, possibly suggestive of declining testicular function. His final height was -2.24 SDS (-2.4 SDS at GH start; MPH -1.6 SDS).
Conclusions:
Our case describes a mild male phenotype associated with 45,X/46,XY mosaicism characterized by unilateral cryptorchidism, spontaneous onset of puberty and normal blood karyotype. The case illustrates the difficulties inherent in making a diagnosis of 45,X/46,XY mosaicism when there is no genital ambiguity, and makes the point that growth and testicular impairment may occur, mostly manifesting during adolescence. An early diagnosis is crucial to initiate careful monitoring for growth and pubertal disorders, increased tumor risk and fertility issues commonly seen in these children. Table 1) .
Anti-mullerian hormone and Inhibin B performed on two occasions (13 and 15 years of age) were normal, but showed a significant decrease over time ( [3, 5] .
Three cases have been reported so far of discordance between blood (46,XY) and gonadal (45,X/46,XY) karyotype [2, 6, 8] . Two patients presented with ambiguous genitalia at the age of 1 year [2] and with a left undescended testis and penoscrotal hypospadias at the age of 16 years [6] , respectively. The third case was a neonate with ambiguous genitalia in whom chromosome Y-derived sequences were detected in the dysgenetic gonad and skin fibroblasts [8] . To our knowledge, our patient is the phenotypically mildest reported case of 45,X/46,XY mosaicism (isolated unilateral impalpable testis with normal male genitalia and spontaneous puberty) diagnosed only on the gonadal karyotype. Nonetheless, in keeping with previously reported cases [7] , from the age of 15 years, our patient showed biochemical features of possible declining testicular function. It is well-known that the majority of 45,X/46,XY patients born with ambiguous genitalia are infertile. However, even in patients with mild phenotypes in childhood, spermatogenesis may be impaired in adulthood [7] . Therefore, at diagnosis, possibilities of fertility preservation should be discussed with the patient and his family [1] . 7 45,X/46,XY patients exhibit an increased tumor risk, not only when abdominal undifferentiated gonads are present, but also in dysgenetic or "apparently normal"
intrascrotal testes [9, 1, 7] . In dysgenetic gonads, the formation of in situ gonadoblastoma or of an invasive germ cell tumor occurs in 15-52% of cases [9] .
However, the risk of germ cell malignancies is mainly defined by histological markers that do not distinguish "maturation-delayed" from "malignant" germ cells, probably leading to an over-diagnosis of cancer and also to over-treatment by gonadectomy [9, 10] . Although in the past gonadectomy was recommended, a more conservative approach is now preferred to allow endogenous hormone production and therefore spontaneous puberty, and to delay irreversible surgery until adulthood. Individualized management has recently been suggested in 45,X/46,XY patients taking into consideration genetic factors, the localization of the gonad, the age and cooperation of the patient, and the histological and immunohistochemical findings [9] [10] [11] . However, it must be pointed out that the risk of progression from histologically malignant lesions to clinical disease with actual morbidity and risk of metastases in these patients is unknown. An international Disorders of Sex Development registry that currently exists will hopefully offer greater insights on the long-term morbidity and mortality associated with malignancies in these patients [11] .
The evidence available on 45,X/46,XY patients suggests that no correlation exists between the clinical phenotype and the degree of mosaicism [4, 5, 7] . The pubertal course, the fertility outcome and the tumor risk seem to be predicted more by degree of genital ambiguity and gonadal differentiation than by the blood/gonadal karyotype [4, 5, 7] . However, most patients, including mild cases without genital ambiguity and those starting puberty spontaneously, will develop some testicular 8 impairment in adolescence or young adulthood [7] . In our case, the preserved gonad maintained sufficient Leydig cell function to induce puberty, but the current hormonal profile possibly suggests declining testicular function, raising concerns for future fertility.
Growth seems to be consistently impaired in these patients [7] . Variable outcomes have been reported on GH treatment with a recent review concluding that, although there may be some short-to mid-term improvement in growth, long-term data on adult height are disappointing [12] . However, supraphysiological GH doses and earlier commencement might result in better outcomes, as could have possibly been the case in our patient. Since fibroblasts have the same mesenchymal origin as chondrocytes and osteoblasts, karyotype from skin fibroblasts could be more useful than the blood karyotype to predict the growth phenotype of these patients [12] . Furthermore, periodic screening for cardiac and autoimmune complications should be considered in 45,X/46,XY patients [13, 14] .
Our case report highlights that 45,X/46,XY mosaicism may present with a very mild phenotype and a normal blood karyotype. Cases without genital ambiguity can be easily missed. However, short stature and decline in testicular function over time are common features, even in mild cases, and these patients also exhibit a significant risk of tumors and infertility. An early diagnosis of gonadal dysgenesis is therefore important in all cases to optimize growth, puberty and fertility outcomes, and to monitor for the increased tumor risk. 
